These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11961033)

  • 1. The ADEMEX Study: make haste slowly.
    Churchill DN
    J Am Soc Nephrol; 2002 May; 13(5):1415-8. PubMed ID: 11961033
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial.
    Paniagua R; Amato D; Vonesh E; Correa-Rotter R; Ramos A; Moran J; Mujais S
    J Am Soc Nephrol; 2002 May; 13(5):1307-1320. PubMed ID: 11961019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ADEMEX study and its implications for peritoneal dialysis adequacy.
    Burkart JM
    Semin Dial; 2003; 16(1):1-4. PubMed ID: 12535290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of recombinant human growth hormone on urea and creatinine kinetics and selected dialysis adequacy parameters in children with end-stage renal failure treated with peritoneal dialysis].
    Jedrzejowski A; Dyras P; Pańczyk-Tomaszewska M; Mizerska-Wasiak M; Roszkowska-Blaim M; Pietrzyk JA; Gałazka B
    Pol Merkur Lekarski; 2002 Sep; 13(75):191-5. PubMed ID: 12474568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneal clearance of inorganic sulfate.
    Uribarri J; Buquing J; Dimaano F; Marcus RG
    Clin Nephrol; 1995 Jul; 44(1):56-9. PubMed ID: 7554534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adequacy of peritoneal dialysis after the ADEMEX study. Back to the basics.
    Tzamaloukas AH; Murata GH
    Int J Artif Organs; 2002 Sep; 25(9):827-31. PubMed ID: 12403397
    [No Abstract]   [Full Text] [Related]  

  • 7. [From CANUSA to ADEMEX: do we need a new paradigm for definition of peritoneal dialysis adequacy?].
    Enia G
    G Ital Nefrol; 2006; 23(6):569-74. PubMed ID: 17173263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clarifying K/DOQI's guideline targets for peritoneal dialysis adequacy.
    Prowant BF
    Nephrol Nurs J; 2001 Aug; 28(4):445-6, 450. PubMed ID: 12143468
    [No Abstract]   [Full Text] [Related]  

  • 9. Peritoneal urea and creatinine clearances in continuous peritoneal dialysis patients with different types of peritoneal solute transport.
    Tzamaloukas AH; Murata GH; Piraino B; Rao P; Bernardini J; Malhotra D; Oreopoulos DG
    Kidney Int; 1998 May; 53(5):1405-11. PubMed ID: 9573559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of prostaglandin E1 on peritoneal membrane transport in CAPD-treated diabetic patients.
    Jaroszynski AJ; Ksiazek A
    Perit Dial Int; 2008; 28(5):538-40. PubMed ID: 18708549
    [No Abstract]   [Full Text] [Related]  

  • 11. The relevance of urea kinetic modeling to CAPD.
    Lysaght MJ; Pollock CA; Hallet MD; Ibels LS; Farrell PC
    ASAIO Trans; 1989; 35(4):784-90. PubMed ID: 2611047
    [No Abstract]   [Full Text] [Related]  

  • 12. The peritoneal equilibration test.
    Peritoneal Dialysis Special Interest Group
    Nephrol Nurs J; 2005; 32(4):452-3. PubMed ID: 16180789
    [No Abstract]   [Full Text] [Related]  

  • 13. Peritoneal dialysis efficiency in CAPD patients in treatment with rHuEPO.
    Vega N; Fernandez A; Hortal L; Macias M; Rodriguez JC; Plaza C; Perdomo M; Vega R; Palop L
    Adv Perit Dial; 1992; 8():467-70. PubMed ID: 1361850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dialysate urea and creatinine concentration at equilibrium, with plasma as a substitute of plasma value for clearance calculations in APD.
    Virga G; Viglino G; Amici G; Gandolfo C; Cavalli PL
    Perit Dial Int; 1996; 16(5):531-3. PubMed ID: 8914185
    [No Abstract]   [Full Text] [Related]  

  • 15. A review of urea and creatinine kinetics in predicting CAPD outcome.
    Campbell D; Fritsche C; Brandes J
    Adv Perit Dial; 1992; 8():79-83. PubMed ID: 1361859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clearance of urea, creatinine, beta 2 microglobulin and the loss of proteins in treatment with continuous ambulatory peritoneal dialysis].
    Kozjak D; Prejac M; Jeren-Struić B; Gudelj J; Kovarbasić B
    Lijec Vjesn; 1982; 104(11-12):532-5. PubMed ID: 6764943
    [No Abstract]   [Full Text] [Related]  

  • 17. [Peritoneal equilibration test and its operation on CAPD patients].
    Wang HJ; Wang CF
    Zhonghua Hu Li Za Zhi; 1997 Feb; 32(2):63-5. PubMed ID: 9369554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal phosphate clearance is influenced by peritoneal dialysis modality, independent of peritoneal transport characteristics.
    Badve SV; Zimmerman DL; Knoll GA; Burns KD; McCormick BB
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1711-7. PubMed ID: 18815242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. We Use Kt/V Urea as a Measure of Adequacy of Peritoneal Dialysis.
    Bargman JM
    Semin Dial; 2016 Jul; 29(4):258-9. PubMed ID: 27081745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of drugs on peritoneal dialysis clearance].
    Djukanović Lj; Ikonomovski J; Milovanović D
    Srp Arh Celok Lek; 1984 Jan; 112(1):115-26. PubMed ID: 6505849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.